Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Top Cited Papers
Open Access
- 26 December 2012
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 308 (24), 2584-2593
- https://doi.org/10.1001/jama.2012.144878
Abstract
Chronic hepatitis C virus (HCV) infection is a major cause of cirrhosis, hepatocellular carcinoma (HCC), and end-stage liver disease. The incidence of HCV-related cirrhosis and its complications is expected to increase in upcoming years.1,2 Davis et al2 estimated that currently 25% of the approximately 3.5 million US patients with chronic HCV infection have cirrhosis and that the proportion of patients with cirrhosis is likely to increase up to 45% by 2030.Keywords
This publication has 6 references indexed in Scilit:
- Faculty Opinions recommendation of A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.Published by H1 Connect ,2016
- Faculty Opinions recommendation of Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.Published by H1 Connect ,2016
- Faculty Opinions recommendation of Outcome of sustained virological responders with histologically advanced chronic hepatitis C.Published by H1 Connect ,2016
- Faculty Opinions recommendation of Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.Published by H1 Connect ,2016
- Faculty Opinions recommendation of Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study.Published by H1 Connect ,2016
- Faculty Opinions recommendation of Multiple imputation of missing blood pressure covariates in survival analysis.Published by H1 Connect ,2008